Our results highlight the importance of considering patient-related and disease-related variables when choosing the most appropriate treatment for each subject affected by psoriasis.

Obesity can negatively affect the short-term and long-term efficacy of biological therapies.

In our analysis, anti-interleukin drugs seem to be more affected by a patient’s weight than anti-tumor necrosis factor drugs.